Stocktoria
Dianthus Therapeutics, Inc. /DE/ DNTH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-06-21
Dianthus Therapeutics, Inc. /DE/ institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 1,648,983 | $138.4M |
| Point72 Asset Management, L.P. | 643,599 | $54.0M |
| BlackRock Finance, Inc. | 1,603,547 | $41.5M |
| MILLENNIUM MANAGEMENT LLC | 261,962 | $22.0M |
| D. E. Shaw & Co., Inc. | 149,609 | $12.6M |
| AQR CAPITAL MANAGEMENT LLC | 4,118 | $345,582 |
Source: SEC EDGAR filings · CIK 0001690585 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.